Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1204838.RADAJtvkMUsSBwm_efcu_-ue98EiOK5Kg1gfA9xy4u5kQ130_assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1204838.RADAJtvkMUsSBwm_efcu_-ue98EiOK5Kg1gfA9xy4u5kQ130_provenance.
• NP262262.RAUpYYuxT1PZ8SLxnDW_8pO-HQ65UWlJJssQor1I81zgU130_assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262262.RAUpYYuxT1PZ8SLxnDW_8pO-HQ65UWlJJssQor1I81zgU130_provenance.
• NP264920.RA5eiioYhFjwOB-Ah60KUqZrPeqWof4F46J_7kl3NIdlg130_assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264920.RA5eiioYhFjwOB-Ah60KUqZrPeqWof4F46J_7kl3NIdlg130_provenance.
• NP609822.RAyjDB5O9OFk3aikQoz98LSMBfJzAjYkFcY-H0hpi-PVQ130_assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609822.RAyjDB5O9OFk3aikQoz98LSMBfJzAjYkFcY-H0hpi-PVQ130_provenance.
• assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1204836.RA4l91eKLoc8DhgKVgFdPBJEsiPYjRPPgF7bCBv2h84As130_assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1204836.RA4l91eKLoc8DhgKVgFdPBJEsiPYjRPPgF7bCBv2h84As130_provenance.
• NP1204837.RAGbT7Ak4gbbbcX3KzVExzChCy7Tu6wpdl-swCCqKlXZM130_assertion description "[Although there are conflicting data regarding prognostic implications of isolated MYC aberrancy in these non-BLs, the co-occurrence of MYC rearrangements and either the antiapoptotic gene B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL2) or the transcriptional repressor BCL6 leads to an entity termed double-hit B-cell lymphoma (DHL) (or triple-hit if all 3 abnormalities are observed) with a particularly poor prognosis and no established treatment paradigms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1204837.RAGbT7Ak4gbbbcX3KzVExzChCy7Tu6wpdl-swCCqKlXZM130_provenance.